KP Tissue Reports Strong Q3 2024 Financial Results

KP Tissue (TSE:KPT) has released an update.

KP Tissue Inc. reported a strong third quarter for 2024, with Kruger Products experiencing a 10.1% revenue increase driven by higher sales volume and favorable prices. Despite rising costs, the company maintained solid adjusted EBITDA and made significant progress with its new manufacturing plant in Sherbrooke, enhancing its production capacity and market share.

For further insights into TSE:KPT stock, check out TipRanks’ Stock Analysis page.

Trending Articles

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.